Multiplikator Forward P/S Biodesix, Inc. (BDSX)

Tandha merek Biodesix, Inc. (BDSX)

The reduction of paper documentation and strict waste disposal create a foundation for the sustainable development of Biodesix, Inc. (BDSX). Modern laboratories in Kansas and Colorado with autonomous power supplies ensure process stability. The future P/S multiple visualizes market expectations, where 1.00 represents the current metric. Meanwhile, financial results are based on insurance reimbursements and the frequency of oncology test prescriptions.

BDSX biodesix.com: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Biodesix, Inc.

- rega pasar lan target rega analis:
Bagan rega Biodesix|BDSX - Target median analis
- rincian kapitalisasi pasar:
Kapitalisasi pasar Biodesix Corporation|BDSX - Rega Tumbas Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Siji Saham Biodesix|BDSX - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku biodesix.com|BDSX - Aset Agregat Perusahaan
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Biodesix, Inc.|BDSX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Biodesix, Inc.|BDSX - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Biodesix Corporation|BDSX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Biodesix|Likuiditas cepet biodesix.com
- data bathi bisnis lan rasio investasi:
BDSX - Asil keuangan resik|Proyeksi bathi mangsa ngarep Biodesix, Inc.|BDSX - Periode bali modal bisnis|Prakiraan rega marang bathi Biodesix Corp|BDSX - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Biodesix Corporation|BDSX - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Biodesix|BDSX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biodesix.com|BDSX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Biodesix, Inc.
- indikator volume dodolan lan pendapatan:
BDSX - Dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Biodesix|BDSX - Koefisien rega marang pendapatan|Multiplikator Forward P/S Biodesix Corporation
Analisis wiwitan perusahaan:Biodesix BDSX
Sampel barang Biodesix, Inc.

Forward P/S determines the market value of one dollar of expected sales, assessing the business's attractiveness for a potential acquisition and the justification of current quotes. By analyzing the forward P/S trend, an investor identifies whether an asset is overbought or reveals hidden risks, which is critical for Biodesix, Inc. (BDSX), whose unique databases and diagnostic speed create high added value in the competitive molecular testing sector.

Analisis pesaing Biodesix, Inc.

Rasio rega marang prakiraan pendapatan Caris Life Sciences CAI|Rasio kapitalisasi marang dodolan sing dikarepake Guardant Health Inc (GH)|Veracyte Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Celcuity Therapeutics CELC|GRAIL, Inc. (GRAL) - Rasio rega marang prakiraan pendapatan|MYGN - Rasio kapitalisasi marang dodolan sing dikarepake|CSTL (Castle Biosciences, Inc.) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan BNR|Multiplikator Forward P/S VNRX|Rasio kapitalisasi marang dodolan sing dikarepake Precipio Inc|Rasio rega marang prakiraan pendapatan Check-Cap CHEK|Mainz Biomed NV (MYNZ) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|OncoCyte - Multiplikator Forward P/S